Beam Therapeutics BEAM
NASDAQ BEAM
$24.52 +0.29 (+1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Total Current Liabilities (2019 - 2026)

Updated

Beam Therapeutics (BEAM) recorded Total Current Liabilities of $80.88 million in Q2 2026, down 53.6% from $174.13 million a year earlier but up 8.5% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Beam Therapeutics reported Total Current Liabilities of $96.94 million, down 46.8% from FY2024.

  • Annual Total Current Liabilities has declined for three straight years, with a five-year compound annual growth rate of -1.1% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $182.07 million in FY2024 (-11.4%), $205.57 million in FY2023 (-8.1%), $223.6 million in FY2022 (+4.8%) and $213.44 million in FY2021 (+108.6%).
  • Quarterly Total Current Liabilities has ranged from $74.57 million in Q1 2026 to $238.86 million in Q3 2022 over the past five years.
  • On a year-over-year basis, Total Current Liabilities has declined for three consecutive quarters, with an average decline of 25.0% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 135.6% in Q3 2022, against a decline of 53.6% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $74.57 million (Q1 2026), $96.94 million (Q4 2025) and $182.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Beam Therapeutics 2.50 Bn 2.50 Bn - 80.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.88 Mn
Mar 31, 2026 74.57 Mn
Dec 31, 2025 96.94 Mn
Sep 30, 2025 182.56 Mn
Jun 30, 2025 174.13 Mn
Mar 31, 2025 141.55 Mn
Dec 31, 2024 182.07 Mn
Sep 30, 2024 166.24 Mn
Jun 30, 2024 177.33 Mn
Mar 31, 2024 187.22 Mn
Dec 31, 2023 205.57 Mn
Sep 30, 2023 220.37 Mn
Jun 30, 2023 209.54 Mn
Mar 31, 2023 219.93 Mn
Dec 31, 2022 223.60 Mn
Sep 30, 2022 238.86 Mn
Jun 30, 2022 212.28 Mn
Mar 31, 2022 218.80 Mn
Dec 31, 2021 213.44 Mn
Sep 30, 2021 101.39 Mn
API Access

Beam Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BEAM&period=max&api_key=YOUR_API_KEY